Core Insights - The article discusses the transformation of supply chain management in the pharmaceutical industry, particularly through the collaboration between Liuyao Group and Huawei Cloud, leveraging AI to optimize complex supply chain operations [4][11][25]. Group 1: Industry Challenges - Liuyao Group faces a complex supply chain with over 10,000 SKUs, multiple warehouses, and stringent compliance and time constraints, which creates a systemic challenge in operations [4][6]. - The pharmaceutical industry is experiencing increased pressure due to the normalization of centralized procurement, stricter cold chain traceability, and comprehensive compliance regulations [6][10]. - The inefficiencies in China's logistics, where logistics costs account for approximately 18% of GDP compared to 8% in the U.S., highlight the need for significant improvements in supply chain efficiency [9][10]. Group 2: AI Integration and Transformation - Liuyao Group has partnered with Huawei Cloud to reconstruct its supply chain decision-making system using AI, focusing on data governance, demand forecasting, and intelligent scheduling [4][11][12]. - The integration of AI technologies, such as data lakes and predictive models, allows for real-time visibility and intelligent decision-making within the supply chain [14][19]. - The AI-driven supply chain system enables Liuyao to optimize complex operations, reducing decision-making time and costs while improving efficiency by 15% to 18% [18][19]. Group 3: Future Trends - By 2027, over 50% of large multinational companies are expected to adopt AI and advanced analytics for supply chain management, indicating a global trend towards intelligent supply chains [8][10]. - In China, over 60% of large enterprises are projected to implement AI and intelligent scheduling systems in key supply chain areas within the next three years, reflecting a structural shift in the industry [10][22]. - The shift from experience-driven to intelligent-driven supply chains is becoming a critical variable in determining operational quality, marking a significant turning point for the pharmaceutical distribution industry [25][26].

Core Viewpoint - The article highlights the transformation of the pharmaceutical supply chain through AI integration, emphasizing the shift from traditional experience-based methods to data-driven, intelligent decision-making systems [2][11][36]. Group 1: Company Overview - Liuyao Group, established in the 1950s, has evolved from a traditional pharmaceutical distributor to a comprehensive health service group, covering hospitals, retail pharmacies, and B2B clients [2]. - The complexity of Liuyao's supply chain is amplified by the need to manage over ten thousand SKUs, multiple warehouses, and stringent compliance and time constraints [2][4]. Group 2: Supply Chain Challenges - Liuyao faces a "triple constraint" in its supply chain, balancing time, compliance, and cost, where improving one aspect can exacerbate the others [4][5]. - The pharmaceutical industry is under pressure to enhance efficiency and reduce costs due to increasing regulatory demands and market competition [7][10]. Group 3: AI Integration and Transformation - Liuyao has partnered with Huawei Cloud to leverage AI for restructuring its supply chain decision-making processes, focusing on data governance, demand forecasting, and intelligent scheduling [2][11]. - The implementation of a data lake has unified fragmented data, enabling real-time visibility and optimization of supply chain operations [15][21]. Group 4: AI Tools and Their Impact - The Pangu predictive model has improved demand forecasting accuracy to over 89%, directly impacting inventory management and reducing stockout risks [16][21]. - The Tianchou AI solver optimizes complex decision-making scenarios, significantly reducing decision-making time and lowering costs by approximately 20% [21][20]. Group 5: Industry Trends and Future Directions - The article notes a global trend where over 50% of large multinational companies are expected to adopt AI and advanced analytics for supply chain management by 2027 [8]. - In China, over 60% of large enterprises are projected to implement AI and intelligent scheduling systems in their supply chains within the next three years, driven by national policies promoting digital transformation [10][11]. Group 6: Conclusion on Supply Chain Evolution - The shift from experience-based systems to computational systems in supply chains is seen as a critical evolution, enabling companies to predict demand, optimize resources, and enhance operational efficiency [26][36]. - Liuyao's experience serves as a model for the industry, demonstrating that intelligent supply chains can become a new growth engine rather than merely a cost center [36].